Glen Santangelo
Stock Analyst at Jefferies
(2.23)
# 1,471
Out of 4,412 analysts
56
Total ratings
46.15%
Success rate
-4.69%
Average return
Main Sectors:
34 Stocks
Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
HIMS Hims & Hers Health | Downgrades: Hold | $17 → $15 | $12.50 | +20.00% | 3 | Apr 16, 2024 | |
TEVA Teva Pharmaceutical | Upgrades: Buy | $10 → $14 | $13.81 | +1.38% | 3 | Jan 23, 2024 | |
COLL Collegium Pharmaceutical | Downgrades: Hold | $30 → $37 | $36.42 | +1.59% | 2 | Jan 4, 2024 | |
ELAN Elanco Animal Health | Initiates: Buy | $17 | $13.26 | +28.21% | 1 | Dec 19, 2023 | |
ZTS Zoetis | Assumes: Buy | $230 | $158.42 | +45.18% | 1 | Dec 19, 2023 | |
VRCA Verrica Pharmaceuticals | Reiterates: Buy | $10 | $6.87 | +45.56% | 2 | Dec 15, 2023 | |
AMPH Amphastar Pharmaceuticals | Reinstates: Buy | $70 | $41.11 | +70.27% | 2 | Jul 25, 2023 | |
ACCD Accolade | Downgrades: Hold | $14 | $7.89 | +77.44% | 2 | Feb 9, 2023 | |
VTRS Viatris | Upgrades: Buy | $13 → $15 | $11.57 | +29.65% | 2 | Jan 27, 2023 | |
SLGL Sol-Gel Technologies | Initiates: Hold | $5.5 | $0.85 | +546.30% | 1 | Oct 21, 2022 | |
XERS Xeris Biopharma Holdings | Assumes: Buy | $4 | $1.75 | +128.57% | 1 | Oct 21, 2022 | |
PHAT Phathom Pharmaceuticals | Initiates: Buy | $16 | $9.18 | +74.29% | 1 | Oct 21, 2022 | |
SCPH scPharmaceuticals | Assumes: Buy | $14 | $4.49 | +211.80% | 1 | Oct 21, 2022 | |
OPTN OptiNose | Assumes: Buy | $5 | $0.86 | +481.13% | 1 | Oct 21, 2022 | |
PCRX Pacira BioSciences | Assumes: Buy | $66 | $26.33 | +150.66% | 1 | Oct 21, 2022 | |
DOCS Doximity | Maintains: Buy | $78 → $46 | $23.82 | +93.12% | 2 | May 18, 2022 | |
HQY HealthEquity | Maintains: Buy | $62 → $80 | $80.26 | -0.32% | 2 | Mar 28, 2022 | |
HCAT Health Catalyst | Upgrades: Buy | $31 → $28 | $6.03 | +364.34% | 2 | Mar 17, 2022 | |
TDOC Teladoc Health | Maintains: Hold | $113 → $82 | $13.01 | +530.28% | 4 | Feb 7, 2022 | |
PHR Phreesia | Initiates: Buy | n/a | $20.61 | - | 1 | Dec 2, 2021 | |
AMWL American Well | Initiates: Hold | n/a | $0.53 | - | 2 | Dec 2, 2021 | |
PGNY Progyny | Initiates: Buy | n/a | $32.04 | - | 3 | Dec 2, 2021 | |
TALK Talkspace | Initiates: Hold | n/a | $3.12 | - | 1 | Dec 2, 2021 | |
GDRX GoodRx Holdings | Initiates: Buy | n/a | $7.19 | - | 1 | Dec 2, 2021 | |
RCM R1 RCM | Initiates: Buy | n/a | $11.90 | - | 1 | Dec 2, 2021 | |
DH Definitive Healthcare | Initiates: Buy | n/a | $6.99 | - | 1 | Dec 2, 2021 | |
CVS CVS Health | Downgrades: Neutral | n/a | $67.18 | - | 2 | Mar 17, 2021 | |
PDCO Patterson Companies | Upgrades: Buy | n/a | $25.77 | - | 1 | Jan 7, 2020 | |
CAH Cardinal Health | Downgrades: Neutral | n/a | $103.21 | - | 2 | Dec 16, 2019 | |
MCK McKesson | Upgrades: Hold | n/a | $543.30 | - | 2 | Jan 25, 2019 | |
HSIC Henry Schein | Maintains: Buy | n/a | $73.13 | - | 2 | Apr 24, 2018 | |
XRAY DENTSPLY SIRONA | Initiates: Buy | n/a | $30.57 | - | 1 | Dec 8, 2017 | |
ALGN Align Technology | Initiates: Hold | n/a | $309.02 | - | 1 | Dec 8, 2017 | |
WBA Walgreens Boots Alliance | Initiates: Hold | n/a | $17.70 | - | 1 | Dec 4, 2017 |
Hims & Hers Health
Apr 16, 2024
Downgrades: Hold
Price Target: $17 → $15
Current: $12.50
Upside: +20.00%
Teva Pharmaceutical
Jan 23, 2024
Upgrades: Buy
Price Target: $10 → $14
Current: $13.81
Upside: +1.38%
Collegium Pharmaceutical
Jan 4, 2024
Downgrades: Hold
Price Target: $30 → $37
Current: $36.42
Upside: +1.59%
Elanco Animal Health
Dec 19, 2023
Initiates: Buy
Price Target: $17
Current: $13.26
Upside: +28.21%
Zoetis
Dec 19, 2023
Assumes: Buy
Price Target: $230
Current: $158.42
Upside: +45.18%
Verrica Pharmaceuticals
Dec 15, 2023
Reiterates: Buy
Price Target: $10
Current: $6.87
Upside: +45.56%
Amphastar Pharmaceuticals
Jul 25, 2023
Reinstates: Buy
Price Target: $70
Current: $41.11
Upside: +70.27%
Accolade
Feb 9, 2023
Downgrades: Hold
Price Target: $14
Current: $7.89
Upside: +77.44%
Viatris
Jan 27, 2023
Upgrades: Buy
Price Target: $13 → $15
Current: $11.57
Upside: +29.65%
Sol-Gel Technologies
Oct 21, 2022
Initiates: Hold
Price Target: $5.5
Current: $0.85
Upside: +546.30%
Xeris Biopharma Holdings
Oct 21, 2022
Assumes: Buy
Price Target: $4
Current: $1.75
Upside: +128.57%
Phathom Pharmaceuticals
Oct 21, 2022
Initiates: Buy
Price Target: $16
Current: $9.18
Upside: +74.29%
scPharmaceuticals
Oct 21, 2022
Assumes: Buy
Price Target: $14
Current: $4.49
Upside: +211.80%
OptiNose
Oct 21, 2022
Assumes: Buy
Price Target: $5
Current: $0.86
Upside: +481.13%
Pacira BioSciences
Oct 21, 2022
Assumes: Buy
Price Target: $66
Current: $26.33
Upside: +150.66%
Doximity
May 18, 2022
Maintains: Buy
Price Target: $78 → $46
Current: $23.82
Upside: +93.12%
HealthEquity
Mar 28, 2022
Maintains: Buy
Price Target: $62 → $80
Current: $80.26
Upside: -0.32%
Health Catalyst
Mar 17, 2022
Upgrades: Buy
Price Target: $31 → $28
Current: $6.03
Upside: +364.34%
Teladoc Health
Feb 7, 2022
Maintains: Hold
Price Target: $113 → $82
Current: $13.01
Upside: +530.28%
Phreesia
Dec 2, 2021
Initiates: Buy
Price Target: n/a
Current: $20.61
Upside: -
American Well
Dec 2, 2021
Initiates: Hold
Price Target: n/a
Current: $0.53
Upside: -
Progyny
Dec 2, 2021
Initiates: Buy
Price Target: n/a
Current: $32.04
Upside: -
Talkspace
Dec 2, 2021
Initiates: Hold
Price Target: n/a
Current: $3.12
Upside: -
GoodRx Holdings
Dec 2, 2021
Initiates: Buy
Price Target: n/a
Current: $7.19
Upside: -
R1 RCM
Dec 2, 2021
Initiates: Buy
Price Target: n/a
Current: $11.90
Upside: -
Definitive Healthcare
Dec 2, 2021
Initiates: Buy
Price Target: n/a
Current: $6.99
Upside: -
CVS Health
Mar 17, 2021
Downgrades: Neutral
Price Target: n/a
Current: $67.18
Upside: -
Patterson Companies
Jan 7, 2020
Upgrades: Buy
Price Target: n/a
Current: $25.77
Upside: -
Cardinal Health
Dec 16, 2019
Downgrades: Neutral
Price Target: n/a
Current: $103.21
Upside: -
McKesson
Jan 25, 2019
Upgrades: Hold
Price Target: n/a
Current: $543.30
Upside: -
Henry Schein
Apr 24, 2018
Maintains: Buy
Price Target: n/a
Current: $73.13
Upside: -
DENTSPLY SIRONA
Dec 8, 2017
Initiates: Buy
Price Target: n/a
Current: $30.57
Upside: -
Align Technology
Dec 8, 2017
Initiates: Hold
Price Target: n/a
Current: $309.02
Upside: -
Walgreens Boots Alliance
Dec 4, 2017
Initiates: Hold
Price Target: n/a
Current: $17.70
Upside: -